4:25 PM ET
8-K
Loan & Debt
Teva Pharmaceutical Industries $3.2B Debt Financing with The Bank of New York Mellon
Teva Pharmaceutical Industries issued a multi-tranche series of senior notes totaling $3.2 billion in USD-denominated notes and €1.5 billion in Euro-denominated notes. The proceeds are intended to fund the redemption of existing debt and for general corporate purposes, effectively refinancing the company's debt maturity profile.
- Value
- $3.2B
- Counterparty
- The Bank of New York Mellon
- Term
- through 2037